Atossa Therapeutics
ATOS
#10748
Rank
S$25.53 M
Marketcap
S$2.56
Share price
1.28%
Change (1 day)
149.46%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -S$48.57 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$44.82 Million a decrease over its 2024 earnings that were of -S$32.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$48.57 Million8.35%
2025 -S$44.82 Million36.33%
2024 -S$32.88 Million-15.25%
2023 -S$38.8 Million11.62%
2022 -S$34.76 Million30.84%
2021 -S$26.57 Million15.58%
2020 -S$22.99 Million3.41%
2019 -S$22.23 Million51.16%
2018 -S$14.71 Million40.41%
2017 -S$10.48 Million27.54%
2016 -S$8.21 Million-47.49%
2015 -S$15.64 Million-17.25%
2014 -S$18.9 Million35.91%
2013 -S$13.91 Million112.3%
2012 -S$6.55 Million46.53%
2011 -S$4.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$24.13 B-49,745.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$1.92 B-4,056.62%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$1.87 B-3,958.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
S$53.72 M-210.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-S$42.46 Million-12.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-S$10.11 Million-79.21%๐Ÿ‡บ๐Ÿ‡ธ USA